SLC27A2 has been reported to regulate the tumor suppressor gene PARP, with reduced levels of SLC27A2 expression in metastatic tumors compared to non-metastatic neuroendocrine tumors (25). Here, SLC27A2 is linked to neuroendocrine neoplasm.